An Ireland South MEP who represents Tipperary believes the country should pay attention to the EU’s General Pharmaceutical Legislation.
Billy Kelleher says the European Commission is proposing to reduce the Regulatory Data Protection for new medicines and drugs from eight years to six which they argue may lead to cheaper drugs.
The Fianna Fail MEP believes this proposed change is a mistake as pharma companies will be less likely to invest in the research and development needed to produce the medicines of the future.
Mr Kelleher says the pharmaceutical sector is as important as the tech sector to Ireland’s prosperity, warning that a bad outcome could jeopardise investment and jobs in Ireland if the EU legislation passes in April.
